DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Cohance Lifesciences Limited — Board Meeting Intimation

NSE 2 hrs ago·23 Jul 2026, 7:05 am

Cohance Lifesciences

Cohance Lifesciences has announced a board meeting scheduled for August 5, 2026. The primary agenda for this meeting is to review and approve the company's unaudited financial results for the quarter ending June 2026.

This announcement is significant for investors as it provides an early indication of the company's short-term financial performance. The unaudited results will offer a preliminary view of the company's operational health and profitability during the first half of the fiscal year.

Investors should watch for the release of the official financial statements following the board's approval. This data will be crucial for assessing the company's growth trajectory and making informed investment decisions.